PMN Stock Analysis: Buy, Sell, or Hold?
PMN - ProMIS Neurosciences Inc. Common Shares (ON)
$14.16
2.15 (17.95%)
▲
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Apr 06, 2026
Get Alerted When PMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called PMN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: PMN is 36.8% above fair value ($10.35). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: PMN is 36.8% above fair value ($10.35). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: PMN is currently trading at $14.16, which is considered extended relative to its 30-day fair value range of $7.03 to $10.35.
Technical Outlook: Technically, PMN is in a strong uptrend. Immediate support is located at $8.08, while resistance sits at $18.70. The stock is showing strong short-term momentum, up 18.0% recently.
Market Sentiment: PMN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $107.52 (+795.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PMN is in a strong uptrend. Immediate support is located at $8.08, while resistance sits at $18.70. The stock is showing strong short-term momentum, up 18.0% recently.
Market Sentiment: PMN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $107.52 (+795.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$7.03 -
$10.35
Company Quality Score
58/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
Protect Your Profits
PMN is technically overbought (RSI 86). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+36.8% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+18.0%)
- BULLISH: Trading 795.7% below Wall St target ($107.52)
- WARNING: Recommendation downgraded due to 36.8% overvaluation
Fair Price Analysis
30-Day Fair Range
$7.03 -
$10.35
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$8.08
Resistance Level
$18.70
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.10
Wall Street Target
$107.52
(+795.7%)
Last updated: January 31, 2026 1:39 AM ET
Data refreshes hourly during market hours. Next update: 2:39 AM
Data refreshes hourly during market hours. Next update: 2:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Max A Milbury
BUY
30392 shares
2025-10-03
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
Advanced PMN Option Strategies
Professional options setups generated by AI based on today's PMN price and gamma walls.
